Please use this identifier to cite or link to this item:
https://doi.org/10.1007/s00280-006-0270-1
| Title: | Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG) | Authors: | Yeo, W. Zee, B. Ma, B. Lam, K.C. Mo, F.K.F. Ng, E.K.W. Ho, R. Chan, A.T.C. Yeo, W. Boyer, M. Clarke, S. Beale, P. Chung, H.C. Roh, J.K. Rha, S.Y. Jeung, H.C. Ong, S.Y.K. Lim, R. Soo, R. Goh, B.C. |
Keywords: | First line chemotherapy Irofulven Stomach cancer |
Issue Date: | 2007 | Citation: | Yeo, W., Zee, B., Ma, B., Lam, K.C., Mo, F.K.F., Ng, E.K.W., Ho, R., Chan, A.T.C., Yeo, W., Boyer, M., Clarke, S., Beale, P., Chung, H.C., Roh, J.K., Rha, S.Y., Jeung, H.C., Ong, S.Y.K., Lim, R., Soo, R., Goh, B.C. (2007). Irofulven as first line therapy in recurrent or metastatic gastric cancer: A phase II multicenter study by the Cancer Therapeutics Research Group (CTRG). Cancer Chemotherapy and Pharmacology 59 (3) : 295-300. ScholarBank@NUS Repository. https://doi.org/10.1007/s00280-006-0270-1 | Source Title: | Cancer Chemotherapy and Pharmacology | URI: | http://scholarbank.nus.edu.sg/handle/10635/27257 | ISSN: | 03445704 | DOI: | 10.1007/s00280-006-0270-1 |
| Appears in Collections: | Staff Publications |
Show full item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.